生物股份(600201.SH)2019年淨利預降66.86%到72.17%
格隆匯1月21日丨生物股份(600201.SH)發佈2019年度業績預告,預計2019年年度實現歸屬於上市公司股東的淨利潤為2.1億元到2.5億元,與上年同期(法定披露數據)相比,將減少5.04億元到5.44億元,同比減少66.86%到72.17%。歸屬於上市公司股東的扣除非經常性損益的淨利潤為2億元到2.4億元,與上年同期(法定披露數據)相比,將減少4.93億元到5.33億元,同比減少67.24%到72.70%。
2019年度受非洲豬瘟疫情影響,能繁母豬和生豬存欄數量大幅減少。公司豬用疫苗產品和市場化業務佔比較高,直接受影響程度較大。受非洲豬瘟疫情的間接影響,公司加強對應收賬款、長期應收款及存貨的審慎管理。除對應收賬款、長期應收款在按照新金融工具準則的要求計提預期信用損失外,還對部分下游客户的信用情況經過審慎評估後進行了壞賬準備的單項計提;同時對存貨在考慮產品效期及期後售價是否低於賬面價值等因素計提了跌價準備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.